Modulation of the gut microbiome and Firmicutes phylum reduction by a nutraceutical blend in the obesity mouse model and overweight humans: a double-blind clinical trial (2024)
- Authors:
- Nehmi Filho, Victor
- Freitas, Jessica Alves de
- Franco, Lucas Augusto
- Martins, Roberta Cristina
- Turri, José Antonio Orellana
- Santamarina, Aline Boveto
- Fonseca, Joyce Vanessa da Silva
- Sabino, Ester Cerdeira
- Moraes, Bruna Carvalho
- Souza, Erica
- Murata, Gilson Masahiro
- Costa, Sílvia Figueiredo
- Alcântara, Paulo Sérgio Martins de
- Otoch, José Pinhata
- Pessoa, Ana Flávia Marçal
- USP affiliated authors: TURRI, JOSÉ ANTONIO ORELLANA - FM ; SABINO, ESTER CERDEIRA - FM ; MURATA, GILSON MASAHIRO - FM ; COSTA, SILVIA FIGUEIREDO - FM ; ALCÂNTARA, PAULO SÉRGIO MARTINS DE - HU ; OTOCH, JOSE PINHATA - HU ; FONSECA, JOYCE VANESSA DA SILVA - FM
- Unidades: FM; HU
- DOI: 10.1002/fsn3.3927
- Subjects: SOBREPESO; PREBIÓTICOS
- Agências de fomento:
- Financiado por Efeom Nutrition S/A
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Processo FAPESP: 18/14389-0 - Financiado pelo FINEP
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Financiado pela Bill & Melinda Gates Foundation
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Food Science & Nutrition
- ISSN: 2048-7177
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
NEHMI FILHO, Victor et al. Modulation of the gut microbiome and Firmicutes phylum reduction by a nutraceutical blend in the obesity mouse model and overweight humans: a double-blind clinical trial. Food Science & Nutrition, 2024Tradução . . Disponível em: https://onlinelibrary.wiley.com/doi/epdf/10.1002/fsn3.3927. Acesso em: 27 abr. 2024. -
APA
Nehmi Filho, V., Freitas, J. A. de, Franco, L. A., Martins, R. C., Turri, J. A. O., Santamarina, A. B., et al. (2024). Modulation of the gut microbiome and Firmicutes phylum reduction by a nutraceutical blend in the obesity mouse model and overweight humans: a double-blind clinical trial. Food Science & Nutrition. doi:10.1002/fsn3.3927 -
NLM
Nehmi Filho V, Freitas JA de, Franco LA, Martins RC, Turri JAO, Santamarina AB, Fonseca JV da S, Sabino EC, Moraes BC, Souza E, Murata GM, Costa SF, Alcântara PSM de, Otoch JP, Pessoa AFM. Modulation of the gut microbiome and Firmicutes phylum reduction by a nutraceutical blend in the obesity mouse model and overweight humans: a double-blind clinical trial [Internet]. Food Science & Nutrition. 2024 ;[citado 2024 abr. 27 ] Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1002/fsn3.3927 -
Vancouver
Nehmi Filho V, Freitas JA de, Franco LA, Martins RC, Turri JAO, Santamarina AB, Fonseca JV da S, Sabino EC, Moraes BC, Souza E, Murata GM, Costa SF, Alcântara PSM de, Otoch JP, Pessoa AFM. Modulation of the gut microbiome and Firmicutes phylum reduction by a nutraceutical blend in the obesity mouse model and overweight humans: a double-blind clinical trial [Internet]. Food Science & Nutrition. 2024 ;[citado 2024 abr. 27 ] Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1002/fsn3.3927 - Novel Nutraceutical (silymarin, yeast & beta;-glucan, prebiotics, and minerals) shifts gut microbiota and restores large intestine histology of diet-induced metabolic syndrome mice
- The role of circulating hormones in cachectic colorectal cancer patients: Insulin, C-peptide, Amylin & Gastric Inhibitory Polypeptide
- Selection and Identification of a DNA Aptamer for Multidrug-Resistant Acinetobacter baumannii Using an In-House Cell-SELEX Methodology
- Análise do custo dos pacientes em lista de espera para o transplante hepático
- Cancer as a Proinflammatory Environment: Metastasis and Cachexia
- Impact of cachexia on circulating inflamatory cytokines on gastrointestinal cancer patients: IL-6 as a potencial biomarker
- Perilipin expression in the subcutaneous adipose tissue in human cancer cachexia
- Neuropeptides, metabolic disorder and inflammation in colon cancer patients: contributing to the cachexia syndrome
- Role of exosomal microRNAs and myomiRs in the development of cancer cachexia-associated muscle wasting
- Contribution of the adipose tissue to cachexia-related systemic inflammation in gastrointestinal cancer patients
Informações sobre o DOI: 10.1002/fsn3.3927 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
